Evidence map›Paper›PMID 31918772›Full record

ArticlePublic health nutrition2020

Intake of

Brandon J Restrepo

Open access · hybridAbstract read
In one paragraph

Article in Public health nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Presence ofNutrients · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Brandon J RestrepoUS Department of Agriculture, Economic Research Service, 355 E. Street SW, Washington, DC20024, USA.ORCID 0000-0002-8005-4839
Economic Research Service · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyse how much the intake of trans-fatty acids (TFA), an important dietary risk factor for CVD, changed among US children and adolescents over a period of time when food regulations that reduced the presence of TFA in the food supply were enacted.

designRegression models were used to estimate changes in levels of TFA in plasma and other CVD risk factors among US children and adolescents from 1999-2000 to 2009-2010.

settingUSA.

participantsNationally representative sample of children (aged 6-11 years) and adolescents (aged 12-19 years) who participated in the 1999-2000 and 2009-2010 cycles of the National Health and Nutrition Examination Survey.

resultsLevels of plasma TFA declined significantly by an average of 61·9 % from 1999-2000 to 2009-2010. The average decline in a TFA commonly found in partially hydrogenated oils (elaidic acid, 67·2 %) was larger than the average decline in a TFA naturally occurring in ruminant animals (vaccenic acid, 60·5 %). Significant improvements in a variety of other CVD risk factors (LDL- and HDL-cholesterol, TAG, systolic and diastolic blood pressure, C-reactive protein) were also observed.

conclusionsBetween the two time points, 1999-2000 and 2009-2010, there were substantial decreases in plasma TFA levels and improvements in several other important CVD risk factors in the population of US children and adolescents.

Indexed as

AdolescentBlood PressureCardiovascular DiseasesChildCholesterol, HDLCholesterol, LDLC-Reactive ProteinDietEatingFemaleFood SupplyHeart Disease Risk FactorsHumansMaleNutrition PolicyNutrition SurveysCholesterol, HDLCholesterol, LDLC-Reactive ProteinTrans Fatty AcidsTriglyceridesAdolescentsChildrenCVDNational Health and Nutrition Examination SurveyTrans-fatty acidsUSA

Identifiers

PMID31918772
PMCPMC10200375
OpenAlexW2999715979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.